ACCESSION: MSBNK-SMB_Measured-HSA015P0257002
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 21
COMMENT: RAW_SPEC {'EL03_pos_2739': {'bp': 214100.0, 'sum': 853376.0}, 'EL18_pos_2505': {'bp': 210263.0, 'sum': 776408.0}, 'EL02_pos_2495': {'bp': 172705.0, 'sum': 716895.0}, 'EL17_pos_2495': {'bp': 160063.0, 'sum': 646024.0}, 'EL01_pos_2500': {'bp': 158873.0, 'sum': 612419.0}, 'EL20_pos_2494': {'bp': 151455.0, 'sum': 624586.0}, 'EL14_pos_2488': {'bp': 143682.0, 'sum': 584215.0}, 'EL19_pos_2524': {'bp': 141809.0, 'sum': 577443.0}, 'EL04_pos_2535': {'bp': 141021.0, 'sum': 587742.0}, 'EL21_pos_2493': {'bp': 139021.0, 'sum': 562814.0}, 'EL13_pos_2500': {'bp': 136768.0, 'sum': 553871.0}, 'EL06_pos_2501': {'bp': 121142.0, 'sum': 532525.0}, 'EL16_pos_2488': {'bp': 119004.0, 'sum': 513940.0}, 'EL05_pos_2501': {'bp': 117573.0, 'sum': 533393.0}, 'EL07_pos_2499': {'bp': 109656.0, 'sum': 460937.0}, 'EL15_pos_2482': {'bp': 107213.0, 'sum': 465373.0}, 'EL08_pos_2501': {'bp': 106681.0, 'sum': 441878.0}, 'EL09_pos_2477': {'bp': 95847.0, 'sum': 439223.0}, 'EL11_pos_2477': {'bp': 95799.0, 'sum': 405266.0}, 'EL10_pos_2499': {'bp': 78560.0, 'sum': 376805.0}, 'EL24_pos_2564': {'bp': 67376.0, 'sum': 349326.0}}
COMMENT: RETENTION_TIME_STDEV 0.076
COMMENT: PRECURSOR_M/Z_RAW 257.113284
COMMENT: PRECURSOR_M/Z_STDEV 0.000124
COMMENT: PRECURSOR_IN_MS1 mz 257.113245; int 26.170; delta(ppm) 1.307278
COMMENT: PROPOSED_CHARGE_STATE +1; mz 258.116693; int 2.953; cor 0.775
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.164; C11H16N2O5; [M+H]+; delta(ppm) 0.163995
COMMENT: PROPOSED_MF MS-FINDER 3.523; C11H16N2O5; [M+H]+; delta(ppm) 0.163091
COMMENT: PROPOSED_MF MS-FINDER 2.380; C12H20N2S2; [M+H]+; delta(ppm) -3.216801
COMMENT: PROPOSED_MF MS-FINDER 2.293; C5H17N6O4P; [M+H]+; delta(ppm) 4.182974
COMMENT: PROPOSED_MF MS-FINDER 2.100; C4H16N8O3S; [M+H]+; delta(ppm) -2.504211
COMMENT: PROPOSED_MF SIRIUS5_Sirius 24.038; C11H16N2O5; [M+H]+; delta(ppm) 0.163091
COMMENT: PROPOSED_MF SIRIUS5_Sirius 19.836; C12H12N6O; [M+H]+; delta(ppm) -5.038537
COMMENT: PROPOSED_MF SIRIUS5_Sirius 5.106; C12H20N2S2; [M+H]+; delta(ppm) -3.216801
COMMENT: PROPOSED_MF SIRIUS5_Sirius 1.090; C15H16N2S; [M+H]+; delta(ppm) 9.894738
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 0.999; C11H16N2O5; [M+H]+; delta(ppm) 0.163091
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 0.001; C12H12N6O; [M+H]+; delta(ppm) -5.038537
COMMENT: PROPOSED_MF SIRIUS6_Sirius 49.181; C11H16N2O5; [M+H]+; delta(ppm) 0.163091
COMMENT: PROPOSED_MF SIRIUS6_Sirius 40.589; C12H12N6O; [M+H]+; delta(ppm) -5.038537
COMMENT: PROPOSED_MF SIRIUS6_Sirius 40.359; C10H20N2O2Si2; [M+H]+; delta(ppm) -199168.255134
COMMENT: PROPOSED_MF SIRIUS6_Sirius 37.507; C9H14N5O4; [M+H]+; delta(ppm) 5.385191
COMMENT: PROPOSED_MF SIRIUS6_Sirius 35.343; C12H17FN2OS; [M+H]+; delta(ppm) 5.450504
COMMENT: PROPOSED_MF SIRIUS6_Sirius 31.904; C9H14F4N3O; [M+H]+; delta(ppm) -5.194271
COMMENT: PROPOSED_MF SIRIUS6_Sirius 28.691; C8H17FN2O6; [M+H]+; delta(ppm) -4.281056
COMMENT: PROPOSED_MF SIRIUS6_Sirius 27.883; C6H17ClN6O3; [M+H]+; delta(ppm) -85371.928669
COMMENT: PROPOSED_MF SIRIUS6_Sirius 27.391; C11H20N2OSSi; [M+H]+; delta(ppm) -199168.824790
COMMENT: PROPOSED_MF SIRIUS6_Sirius 27.113; C8H18F2N2O3Si; [M+H]+; delta(ppm) -199166.116365
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C11H16N2O5; [M+H]+; delta(ppm) 0.163091
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 1.029; MAKBMGXNXXXBFE-TURQNECASA-N; [M+H]+; NC(=O)C1=CN(C=CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.684; LOSQXYOWYFPTDX-YZYOREDDNA-N; [M+H]+; CC#CC[C@H](NC(=O)CC[C@H](N)C(O)=O)C(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.576; OYFFZHHPKZICIV-DCQUZPHYNA-N; [M+H]+; N[C@@H](CCC(=O)N[C@H](C(O)=O)C(=C)C=C)C(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.570; GYLYZVSBBQFIGV-WHOSYVTDNA-N; [M+H]+; N[C@@H](CCC(=O)N[C@@H]([C@H]1CC1=C)C(O)=O)C(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.486; DPDYTYOWSIRPMB-UHFFFAOYSA-N; [M+H]+; C1=CC=C(C=C1)CN2C3=C(C(=O)NC(=N3)N)N=C2N
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.861; MAKBMGXNXXXBFE-TURQNECASA-N; [M+H]+; 1-(beta-D-Ribofuranosyl)-1,4-dihydronicotinamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.685; LOSQXYOWYFPTDX-YZYOREDDNA-N; [M+H]+; UNPD30953
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.620; GYLYZVSBBQFIGV-WHOSYVTDNA-N; [M+H]+; UNPD146996
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.589; AVPVIAPNMXZVAE-JYPKXMCJSA-N; [M+H]+; (2S)-2-ammonio-5-[(1,6-dihydroxycyclohexa-2,4-dien-1-yl)amino]-5-keto-valerate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.563; XACKNLSZYYIACO-PQCSWJAFNA-N; [M+H]+; edoxudine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.548; OYFFZHHPKZICIV-DCQUZPHYNA-N; [M+H]+; UNPD73591
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.548; UPSXYNJDCKOCFD-UHFFFAOYSA-N; [M+H]+; 2-(2-aminopropanoylamino)bicyclo[3.1.0]hexane-2,6-dicarboxylic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.540; QFVJRGJHSZSRJI-UHFFFAOYNA-N; [M+H]+; 5-ethyl-1-[4-hydroxy-3-(hydroxymethyl)-2-oxolanyl]pyrimidine-2,4-dione
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.479; KTCKNHCDUKONFQ-DJLDLDEBSA-N; [M+H]+; 1-[(2R,4S,5R)-4-hydroxy-5-(methoxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.472; IPDRTIBDOPMMIQ-VAOFZXAKSA-N; [M+H]+; 1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)-2-methyloxolan-2-yl]-5-methylpyrimidine-2,4-dione
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.418; JCVDICFLPGDHAT-DJLDLDEBSA-N; [M+H]+; 1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3,5-dimethylpyrimidine-2,4-dione
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.301; HWCQCFUPVMSAPA-UHFFFAOYSA-N; [M+H]+; 2-(hydroxymethyl)-6-[(pyridin-2-yl)amino]oxane-3,4,5-triol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.223; FQVAVWDFRFLFFW-UHFFFAOYSA-N; [M+H]+; 5-carbamoyl-1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]piperidin-1-ium-2-yl
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.126; FVHRPUUIQXSRLE-UHFFFAOYSA-N; [M+H]+; CNP0431837
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; LOSQXYOWYFPTDX-YZYOREDDNA-N; [M+H]+; UNPD30953
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.996; GYLYZVSBBQFIGV-WHOSYVTDNA-N; [M+H]+; UNPD146996
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.996; OYFFZHHPKZICIV-DCQUZPHYNA-N; [M+H]+; UNPD73591
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.977; MAKBMGXNXXXBFE-TURQNECASA-N; [M+H]+; 1-(beta-D-Ribofuranosyl)-1,4-dihydronicotinamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.948; AVPVIAPNMXZVAE-JYPKXMCJSA-N; [M+H]+; (2S)-2-ammonio-5-[(1,6-dihydroxycyclohexa-2,4-dien-1-yl)amino]-5-keto-valerate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.932; UPSXYNJDCKOCFD-UHFFFAOYSA-N; [M+H]+; 2-(2-aminopropanoylamino)bicyclo[3.1.0]hexane-2,6-dicarboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.447; FQVAVWDFRFLFFW-UHFFFAOYSA-N; [M+H]+; 5-carbamoyl-1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]piperidin-1-ium-2-yl
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.381; QFVJRGJHSZSRJI-UHFFFAOYNA-N; [M+H]+; 5-ethyl-1-[4-hydroxy-3-(hydroxymethyl)-2-oxolanyl]pyrimidine-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.381; XACKNLSZYYIACO-PQCSWJAFNA-N; [M+H]+; edoxudine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.333; JCVDICFLPGDHAT-DJLDLDEBSA-N; [M+H]+; 1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3,5-dimethylpyrimidine-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.268; HWCQCFUPVMSAPA-UHFFFAOYSA-N; [M+H]+; 2-(hydroxymethyl)-6-[(pyridin-2-yl)amino]oxane-3,4,5-triol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.263; KTCKNHCDUKONFQ-DJLDLDEBSA-N; [M+H]+; 1-[(2R,4S,5R)-4-hydroxy-5-(methoxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.039; IPDRTIBDOPMMIQ-VAOFZXAKSA-N; [M+H]+; 1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)-2-methyloxolan-2-yl]-5-methylpyrimidine-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.287; XACKNLSZYYIACO-DJLDLDEBSA-N; [M+H]+; 5-ethyl-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.692; MAKBMGXNXXXBFE-TURQNECASA-N; [M+H]+; 1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-4H-pyridine-3-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.621; JCVDICFLPGDHAT-DJLDLDEBSA-N; [M+H]+; 1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3,5-dimethylpyrimidine-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.412; AVPVIAPNMXZVAE-JYPKXMCJSA-N; [M+H]+; (2S)-2-amino-5-[(1,6-dihydroxycyclohexa-2,4-dien-1-yl)amino]-5-oxopentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.250; NJDDBFWJDXNNGL-UHFFFAOYSA-N; [M+H]+; [2-hydroxy-3-(2-methoxyphenoxy)propyl] N-aminocarbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.243; SIICJKIFRURZFO-UHFFFAOYSA-N; [M+H]+; 2-(3,4,5-trimethoxyphenoxy)acetohydrazide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.236; UPSXYNJDCKOCFD-QIMCWZKGSA-N; [M+H]+; (1S,2S,5R,6S)-2-[[(2S)-2-aminopropanoyl]amino]bicyclo[3.1.0]hexane-2,6-dicarboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.908; IKHLDZHANQNTMR-UHFFFAOYSA-N; [M+H]+; ethyl 3-[(2-methylpropan-2-yl)oxycarbonylamino]-1,2-oxazole-4-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.590; DUJPDBHMHIVXOJ-VIFPVBQESA-N; [M+H]+; (2S)-3-hydroxy-2-[[3-hydroxy-5-(hydroxymethyl)-2-methylpyridin-4-yl]methylamino]propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.381; VAASDFPRJZEMMO-UHFFFAOYSA-N; [M+H]+; 2-O-tert-butyl 4-O-ethyl 5-oxo-1H-pyrazole-2,4-dicarboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.337; BJTWTFAZBOWXSI-UHFFFAOYSA-N; [M+H]+; 4-[[bis(2-hydroxyethyl)amino]methyl]-2-nitrophenol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.303; JENSYBUZSUONAU-UHFFFAOYSA-N; [M+H]+; 5-[2-[(2-methylpropan-2-yl)oxycarbonylamino]ethyl]-1,2-oxazole-3-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.301; SKQJJNVLRHAHTK-UHFFFAOYSA-N; [M+H]+; 2-ethyl-5-(6-hydroxy-2,4-dioxo-1H-pyrimidin-5-yl)pentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.294; KRMNIBRMACJMFG-UHFFFAOYSA-N; [M+H]+; 2-[(2-methylpropan-2-yl)oxycarbonylamino]-3-(1,3-oxazol-5-yl)propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.283; LZOVRFNJESHFCK-UHFFFAOYSA-N; [M+H]+; 2-[2-[(2-methylpropan-2-yl)oxycarbonylamino]ethyl]-1,3-oxazole-4-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.281; HSBSFXGYYQDTBF-UHFFFAOYSA-N; [M+H]+; 2-[(2-methylpropan-2-yl)oxycarbonyl]-5-oxa-2,6-diazaspiro[3.4]oct-6-ene-7-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.278; BZURFLDHYTVNHC-UHFFFAOYSA-N; [M+H]+; 4-methyl-2-[[(2-methylpropan-2-yl)oxycarbonylamino]methyl]-1,3-oxazole-5-carboxylic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -150.884; XACKNLSZYYIACO; [M+H]+; Edoxudin
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -154.284; KTCKNHCDUKONFQ; [M+H]+; Thymidine, 5''-O-methyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -164.153; OVADECQWSOWNFN; [M+H]+; O(2)-Methyldeoxythymidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -165.052; JCVDICFLPGDHAT; [M+H]+; Ambcb5487271
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -166.043; ZGBKEOLAPVBJFC; [M+H]+; 3''-O-Methylthymidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -169.969; SYCUMVXQKYPFDT; [M+H]+; 4-O-Methylthymidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -206.429; QFVJRGJHSZSRJI; [M+H]+; Spectrum_000009
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -277.355; HWCQCFUPVMSAPA; [M+H]+; N-pyridin-2-ylhexopyranosylamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -287.961; MAKBMGXNXXXBFE; [M+H]+; Reduced nicotinamide riboside
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -297.716; LOSQXYOWYFPTDX; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -317.262; OJXPFADDQWSTJY; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -354.273; WHOXODNEBMKFGY; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -355.050; SKQJJNVLRHAHTK; [M+H]+; 2-ethyl-5-(2,4,6-trihydroxypyrimidin-5-yl)pentanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -368.530; GYLYZVSBBQFIGV; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -370.014; OYFFZHHPKZICIV; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -443.305; AVPVIAPNMXZVAE; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -461.729; NJDDBFWJDXNNGL; [M+H]+; 1,2-Propanediol, 3-(o-methoxyphenoxy)-, carbazate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -471.018; UPSXYNJDCKOCFD; [M+H]+; Talaglumetad
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -520.791; HMZMIBPZIFJSLM; [M+H]+; 3-[4,5-dihydroxy-2-(hydroxymethylamino)phenyl]-2-(methylamino)propanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -556.854; SIICJKIFRURZFO; [M+H]+; 3,4,5-Trimethoxyphenoxyacetohydrazide
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.320; XACKNLSZYYIACO; [M+H]+; Edoxudin
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -177.810; XACKNLSZYYIACO; [M+H]+; 5-ethyl-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -188.427; JCVDICFLPGDHAT; [M+H]+; 3-Methylthymidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -193.932; ZGBKEOLAPVBJFC; [M+H]+; 3'-O-Methyl Thymidine-d3
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -196.657; KTCKNHCDUKONFQ; [M+H]+; 1-[(2S,4R,5S)-4-hydroxy-5-(methoxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -211.577; SYCUMVXQKYPFDT; [M+H]+; O-Methylthymidine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -217.079; OVADECQWSOWNFN; [M+H]+; 1-[(2R,4R,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-methoxy-5-methylpyrimidin-4-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -248.536; IPDRTIBDOPMMIQ; [M+H]+; 1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)-2-(114C)methyloxolan-2-yl]-5-methylpyrimidine-2,4-dione
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -250.675; QFVJRGJHSZSRJI; [M+H]+; 5-ethyl-4-hydroxy-1-[4-hydroxy-3-(hydroxymethyl)oxolan-2-yl]-1,2-dihydropyrimidin-2-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -261.425; HWCQCFUPVMSAPA; [M+H]+; 2-(hydroxymethyl)-6-[(pyridin-2-yl)amino]oxane-3,4,5-triol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -289.970; MAKBMGXNXXXBFE; [M+H]+; 1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,4-dihydropyridine-3-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.456; XACKNLSZYYIACO; [M+H]+; 5-ethyl-1-[4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C11H17N2O5; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1), SIRIUS5_Sirius(1), SIRIUS5_Zodiac(1);
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 µm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 4.055
MS$FOCUSED_ION: PRECURSOR_M/Z 257.113240
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0a4i-3590000000-428266ef988129183639
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  53.0388356 33.2840 53.039533 1.0370 6.23 0.8358 17 f{C4H5}/4.88ppm,p-C7H12N2O5
  55.0544592 26.0444 55.055167 1.1080 6.41 0.6451 20 f{C4H7}/4.22ppm,p-C7H10N2O5
  56.0496891 20.5988 56.050401 1.5344 5.76 0.1353 16 f{C3H6N1}/3.81ppm,p-C8H11N1O5
  57.0701421 94.9557 57.070859 0.6834 28.61 0.2896 21 f{C4H9}/4.65ppm,p-C7H8N2O5
  58.0653591 22.3597 58.066079 1.6016 11.26 -0.2745 17 f{C3H8N1}/4.02ppm,p-C8H9N1O5
  69.0336408 38.2614 69.034384 1.1299 6.61 0.7818 21 f{C4H5O1}/2.17ppm,p-C7H12N2O4
  69.0699965 29.3364 69.070740 1.0859 8.16 0.3807 19 f{C5H9}/1.73ppm,p-C6H8N2O5
  71.0856594 26.9571 71.086403 0.7737 8.28 0.4404 19 f{C5H11}/1.87ppm,p-C6H6N2O5
  74.0601381 20.4516 74.060879 1.3503 6.34 0.2033 18 f{C3H8N1O1}/1.32ppm,p-C8H9N1O4
  80.0495724 56.1887 80.050302 1.1618 9.98 0.8545 21 f{C5H6N1}/1.21ppm,p-C6H11N1O5
  81.0698798 25.2290 81.070606 1.1965 9.76 0.1471 16 f{C6H9}/0.04ppm,p-C5H8N2O5
  82.0651617 119.0593 82.065885 0.6336 13.56 0.9584 21 f{C5H8N1}/0.44ppm,p-C6H9N1O5
  84.0444863 28.1673 84.045202 1.1185 11.72 0.2429 21 f{C4H6N1O1}/1.14ppm,p-C7H11N1O4
  85.0284032 19.1553 85.029115 1.5995 6.43 0.3679 15 f{C4H5O2}/-0.03ppm,p-C7H12N2O3
  88.0757322 68.3174 88.076429 0.9424 21.34 -0.1571 21 f{C4H10N1O1}/0.48ppm,p-C7H7N1O4
  96.0444430 23.6745 96.045088 1.1453 7.68 0.5833 17 f{C5H6N1O1}/0.55ppm,p-C6H11N1O4
  97.0284578 30.8883 97.029095 1.4017 6.90 0.7614 19 f{C5H5O2}/0.54ppm,p-C6H12N2O3
  102.0913710 37.2747 102.091964 1.0971 13.83 -0.0093 18 f{C5H12N1O1}/0.30ppm,p-C6H5N1O4
  108.0444374 557.9879 108.044973 0.3425 39.21 0.9805 21 f{C6H6N1O1}/0.44ppm,p-C5H11N1O4
  125.0709810 401.0515 125.071370 0.4398 39.50 0.9623 21 f{C6H9N2O1}/0.33ppm,p-C5H8O4
  149.0233838 106.1389 149.023682 0.7985 12.84 0.9416 21 f{C8H5O3}/0.43ppm,p-C3H12N2O2
  240.0866312 350.6085 240.086990 0.6164 23.24 0.9597 21 f{C11H14N1O5}/-0.07ppm,p-H3N1
  256.2634755 493.1123 256.263849 0.4292 147.20 0.1455 21 ?
  257.1131482 999.0000 257.113523 0.4084 0.00 1.0000 21 f{C11H17N2O5}/-0.19ppm,p
  257.2666622 87.0669 257.267037 1.1739 31.81 -0.0809 17 ?
PK$NUM_PEAK: 25
PK$PEAK: m/z int. rel.int.
  53.038836 33.28 33
  55.054459 26.04 26
  56.049689 20.60 20
  57.070142 94.96 94
  58.065359 22.36 22
  69.033641 38.26 38
  69.069997 29.34 29
  71.085659 26.96 26
  74.060138 20.45 20
  80.049572 56.19 56
  81.069880 25.23 25
  82.065162 119.06 119
  84.044486 28.17 28
  85.028403 19.16 19
  88.075732 68.32 68
  96.044443 23.67 23
  97.028458 30.89 30
  102.091371 37.27 37
  108.044437 557.99 557
  125.070981 401.05 401
  149.023384 106.14 106
  240.086631 350.61 350
  256.263476 493.11 493
  257.113148 999.00 999
  257.266662 87.07 87
//
